WHO expert meeting in Hong Kong advances international herbal pharmacopoeia
WHO experts from six regions met in Hong Kong to review quality specifications for 12 herbs and the first volume of an international herbal pharmacopoeia. Hong Kong's health officials highlighted the city's role in setting traditional medicine standards under national and local plans.
World Health Organization (WHO) experts from six regions – Africa, the Americas, the Eastern Mediterranean, Europe, South-East Asia and the Western Pacific – gathered in Hong Kong on 16 November 2026 to advance work on an international herbal pharmacopoeia. The meeting reviewed proposed quality specifications for 12 medicinal plants and examined the first volume of the pharmacopoeia.
Liu Jinfeng, Vice-Minister of the National Health Commission and head of the National Administration of Traditional Chinese Medicine, addressed the opening ceremony by video link. He said traditional medicine plays an important role in global health systems and complements modern medicine. He called for a science-based, collaborative and people-centred approach in developing the pharmacopoeia, citing the Beijing Initiative on the Protection and Sustainable Use of Traditional Medicinal Plants.
Dr Lam Man-kin, Director of the Hong Kong Department of Health, said the meeting provided a platform for experts to exchange knowledge and improve consistency in herbal quality standards. He noted that the department's Chinese Medicine Regulatory Office, a WHO collaborating centre for traditional medicine, co-hosted the meeting with India's Pharmacopoeia Commission for Indian Medicine and Homoeopathy.
Dr Lam said Hong Kong's first five-year economic and social development plan (2026–2030) and the 2026 Policy Address both support the city's Government Chinese Medicines Testing Centre in using WHO platforms to help set international standards for Chinese medicine. He said this would help overseas markets recognise Chinese medicine products and align standards globally.
WHO officials said the international herbal pharmacopoeia is a key part of the WHO Global Traditional Medicine Strategy 2025–2034. Kim Seung-cheol, head of the WHO Centre for Traditional Medicine's unit on regulation, standards and systems integration, said the pharmacopoeia would strengthen quality assurance and regulatory capacity.
Hong Kong's Chinese Medicines Standards (CMSS) programme has set standards for 357 herbs through an international expert committee and published 12 volumes. The Department of Health plans to establish a Drug and Medical Device Regulatory Authority this year to integrate regulation of Western and Chinese medicines and medical devices. The government aims to position Hong Kong as a gateway for Chinese medicine to reach global markets under the national Healthy China strategy.